› Forums › General Melanoma Community › Stage 3c melanoma
- This topic has 4 replies, 3 voices, and was last updated 5 years, 12 months ago by
KellyH.
- Post
-
- March 18, 2019 at 7:55 pm
My 35 year old son was diagnosed with stage 3c melanoma in November 2018. He has blue cross blue shield insurance and just received letter from them that they will no longer pay for his IV nivolumab immunotherapy after September of 2919. He is supposed to be on this treatment for two years, he started first treatment in January of 2019. I told him to have his oncologist write an appeal letter to insurance company. Does anyone have any advice on what steps we can take so my son can continue treatments, any help would be greatly appreciated.
- Replies
-
-
- March 18, 2019 at 7:59 pm
Sorry I had typo insurance wants to only pay until Sept 2019
-
- March 18, 2019 at 11:37 pm
Stage 3-C resected melanoma should be 1 year of treatment. That is the standard of care used in clinical trials. Sometimes the insurance company will pre approve for only six months and then send another approval later. I will bet the docs will get it worked out..
Susanne
-
- March 19, 2019 at 12:25 am
I also have Blue Cross and Blue Shield…and my son’s Nivo treatments were approved 6 months at a time. He completes his one year of adjuvant treatment this May.
I think the doctors should be able to work it out with the insurance company based on what is the standard of care for Stage 3c.
Good luck and best wishes for a successful course of treatment!!!!
Kelly 🙂
-
- You must be logged in to reply to this topic.